| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 乙酸阿比特龙酯; Abiraterone Acetate | CFN90022 | 154229-18-2 | C26H33NO2 = 391.55 | 5mg | QQ客服：215959384 |
| 5-[(2R)-2-氨基丙基]-2,3-二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石酸盐; 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate | CFN90023 | 239463-85-5 | C26H31N3O8 = 513.55 | 5mg | QQ客服：215959384 |
| 鸭脚树叶碱; Picrinine | CFN98700 | 4684-32-6 | C20H22N2O3 = 338.4 | 5mg | QQ客服：3257982914 |
| 组胺; Histamine | CFN90029 | 51-45-6 | C5H9N3 = 111.15 | 20mg | QQ客服：1413575084 |
| 腺苷环磷酸酯; Adenosine cyclophosphate | CFN90031 | 60-92-4 | C10H12N5O6P = 329.21 | 20mg | QQ客服：2159513211 |
| 肾上腺素; Adrenaline | CFN90032 | 51-43-4 | C9H13NO3 = 183.2 | 20mg | QQ客服：2056216494 |
| 1-甲基斯佩加春; N-Methylsarpagine methosalt | CFN98712 | 47418-70-2 | C21H27N2O2 = 339.5 | 5mg | QQ客服：2056216494 |
| 鹅掌楸碱; Liriodenine | CFN98715 | 475-75-2 | C17H9NO3 = 275.3 | 5mg | QQ客服：215959384 |
| 盐酸多巴胺; Dopamine hydrochloride | CFN90036 | 62-31-7 | C8H11NO2 = 153.18 | 20mg | QQ客服：2159513211 |
| 松果体素; Melatonin | CFN90037 | 73-31-4 | C13H16N2O2 = 232.28 | 20mg | QQ客服：1457312923 |
| 氯化乙酰胆碱； 乙酰氯化胆碱; Acetylcholine chloride | CFN90038 | 60-31-1 | C7H16ClNO2 = 181.66 | 20mg | QQ客服：3257982914 |
| 波尔定碱; Boldine | CFN98718 | 476-70-0 | C19H21NO4 = 327.4 | 20mg | QQ客服：2056216494 |
| 异汉防己甲素; Isotetrandrine | CFN98722 | 477-57-6 | C38H42N2O6 = 622.8 | 5mg | QQ客服：215959384 |
| 新斯替宁碱; Neostenine | CFN98725 | 477953-07-4 | C17H27NO2 = 277.4 | 5mg | QQ客服：3257982914 |
| 小檗胺; Berbamine | CFN98727 | 478-61-5 | C37H40N2O6 = 608.7 | 20mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)